This inventor holds 1 USPTO granted patent. Top assignee: Knoll Aktiengesellschaft. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Christa Raab: Innovator in Medical Treatments
Introduction
Christa Raab is a notable inventor based in Dannstadt-Schauernheim, Germany. She has made significant contributions to the field of medicine, particularly in the development of treatments for disorders associated with elevated serum levels of interleukin-6. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to improving healthcare.
Latest Patents
Christa Raab holds a patent for the "Use of anti-TNF antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6." This invention relates to the use of TNF antagonists for producing drugs aimed at treating disorders characterized by elevated serum levels of interleukin-6. This patent highlights her commitment to advancing medical science and providing new therapeutic options for patients.
Career Highlights
Throughout her career, Christa Raab has been associated with Knoll Aktiengesellschaft, a company known for its focus on pharmaceutical innovations. Her work at this organization has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to medical research and development.
Collaborations
Some of her notable coworkers include Roswitha Stenzel and Martin Kaul. Their collaborative efforts have played a crucial role in the success of various projects and innovations within the company.
Conclusion
Christa Raab's contributions to the field of medicine through her patent and work at Knoll Aktiengesellschaft demonstrate her dedication to improving patient care. Her innovative spirit continues to inspire others in the medical research community.